GROSSO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 774
EU - Europa 437
AS - Asia 186
AF - Africa 51
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.451
Nazione #
US - Stati Uniti d'America 755
GB - Regno Unito 129
CN - Cina 107
IT - Italia 66
DE - Germania 61
SE - Svezia 50
SG - Singapore 43
RU - Federazione Russa 23
TG - Togo 22
CA - Canada 19
IN - India 18
CI - Costa d'Avorio 17
IE - Irlanda 17
BE - Belgio 16
UA - Ucraina 16
FR - Francia 12
EE - Estonia 11
CH - Svizzera 10
ZA - Sudafrica 10
BG - Bulgaria 7
FI - Finlandia 6
JP - Giappone 6
RO - Romania 5
JO - Giordania 4
NL - Olanda 4
ID - Indonesia 3
LT - Lituania 3
IR - Iran 2
KR - Corea 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
NG - Nigeria 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 1.451
Città #
Southend 112
Fairfield 88
Chandler 85
Ann Arbor 75
Ashburn 71
Wilmington 53
Woodbridge 48
Houston 45
Singapore 41
Seattle 37
Cambridge 34
Princeton 26
Lomé 22
Santa Clara 19
Abidjan 17
Dublin 17
Brussels 16
Beijing 15
Bologna 15
Ottawa 15
Boardman 14
Nanjing 12
Bremen 11
Padova 11
Westminster 11
Berlin 9
Bern 9
Jinan 9
San Diego 8
Changsha 7
Guangzhou 7
Jacksonville 7
Redmond 7
Redwood City 7
Sofia 7
Tianjin 7
Tokyo 6
Turin 6
Helsinki 5
Milan 5
Nanchang 5
Saint Petersburg 5
Amman 4
Jiaxing 4
London 4
Ningbo 4
Chieti 3
Hebei 3
Jakarta 3
Phoenix 3
Shenyang 3
Toronto 3
Amsterdam 2
Bühl 2
Casalecchio di Reno 2
Falkenstein 2
Haikou 2
Incheon 2
Lanzhou 2
Los Angeles 2
Montechiarugolo 2
Moscow 2
Shanghai 2
Washington 2
Xiangfen 2
Alexandria 1
Baoding 1
Bochum 1
Bulle 1
Cagliari 1
Centro 1
Chengdu 1
Dearborn 1
Des Moines 1
Frankfurt Am Main 1
Fuzhou 1
Grafing 1
Hangzhou 1
Kiev 1
Kuban 1
Lagos 1
Lappeenranta 1
Las Vegas 1
Leawood 1
Mahé 1
Montreal 1
Mülheim 1
Olalla 1
Riccione 1
Riyadh 1
San Francisco 1
San Jose 1
San Venanzo 1
Shenzhen 1
Shijiazhuang 1
São Paulo 1
Taiyuan 1
Taizhou 1
Tallinn 1
Verona 1
Totale 1.121
Nome #
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 169
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 158
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy 155
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2. 139
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor 136
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice. 130
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 129
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines 128
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. 121
High metastatic efficiency of human sarcoma cells in Rag2/gamma c double knockout mice provides a powerful test system for antimetastatic targeted therapy 115
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas 112
Totale 1.492
Categoria #
all - tutte 3.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020256 0 0 0 0 0 0 54 61 65 40 16 20
2020/2021163 46 14 10 9 2 7 4 17 21 8 12 13
2021/2022217 13 4 24 9 23 11 7 16 6 15 60 29
2022/2023320 35 56 17 52 19 18 8 18 39 16 27 15
2023/202482 3 15 3 11 8 11 5 14 1 4 3 4
2024/2025163 25 29 27 13 39 28 2 0 0 0 0 0
Totale 1.492